Enzymatic Mechanisms, Metabolism & Novel Therapeutic Targets | Session Summary and Speakers

This session at the 2nd International Virtual Conference on Staphylococci and Staphylococcal Infections (February 23–24, 2026) will spotlight enzymatic pathways, metabolic regulation, and emerging therapeutic targets that shape 𝘚𝘵𝘢𝘱𝘩𝘺𝘭𝘰𝘤𝘰𝘤𝘤𝘶𝘴 𝘢𝘶𝘳𝘦𝘶𝘴 physiology, persistence, and drug susceptibility.

Benedykt Wladyka (Jagiellonian University, Poland) will discuss peptidoglycan hydrolases as powerful anti-𝘚𝘵𝘢𝘱𝘩𝘺𝘭𝘰𝘤𝘰𝘤𝘤𝘶𝘴 𝘢𝘶𝘳𝘦𝘶𝘴 agents; Don Ronning (University of Nebraska Medical Center, USA) will explore how understanding 𝘚. 𝘢𝘶𝘳𝘦𝘶𝘴 tolerance to D-cycloserine can be leveraged for novel drug discovery; and Ronan Carroll (Ohio University, USA) will present insights into the role of adenosine deaminase TadA in 𝘚𝘵𝘢𝘱𝘩𝘺𝘭𝘰𝘤𝘰𝘤𝘤𝘶𝘴 𝘢𝘶𝘳𝘦𝘶𝘴 biology and regulation.

The session will be chaired by Emily Felton (University of South Florida), who will be guiding discussion and fostering scientific exchange on enzymatic mechanisms, metabolism, and innovative therapeutic targets.

Together, these talks provide an integrated view of how enzymatic function and metabolic control govern bacterial survival and antibiotic response, highlighting promising molecular targets for next-generation anti-staphylococcal therapies.

Dates – February 23–24, 2026

Download the full program – https://staph.ircconferences.net/

Join now to hear from leading experts advancing innovative strategies to target 𝘚𝘵𝘢𝘱𝘩𝘺𝘭𝘰𝘤𝘰𝘤𝘤𝘶𝘴 𝘢𝘶𝘳𝘦𝘶𝘴 through enzymology and metabolic intervention.

This conference is organized by Impact Research Communications (IRC)

More info: https://staph.ircconferences.net/ | Staphylococcus Science & Therapeutics